BioInvent Enrolls First Patient in Phase 1/2a Clinical Trial

BioInvent Enrolls First Patient in Phase 1/2a Clinical Trial with TNFR2 Antibody BI-1910

BioInvent Enrolls First Patient in Phase 1/2a Clinical Trial with TNFR2 Antibody BI-1910

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Stockholm , Sweden , Martin Welschof , Cecilia Hofvander , Bioinvent International Ab Nasdaq Stockholm , Bioinvent International , Bioinvent International Ab , Nasdaq Stockholm , Senior Director Investor ,